Skip to main content
SpringerLink
Log in

Immunizations in the Child with Sickle Cell Disease

  • Chapter
  • First Online:
Benign Hematologic Disorders in Children

Abstract

In order to provide optimal health maintenance, clinicians who care for children with sickle cell disease (SCD) including the most common form, sickle cell anemia (SCA, HbSS, and HbS/beta-thalassemia°) as well as HbSC and HbS/beta-thalassemia+, should be aware of the immune deficits that accompany the disorder which dictate a modified vaccination schedule for certain vaccines in this specialized population. The potential deficits of the immune system along with the recommended vaccination schedule for the child with SCD are described for the primary care clinician.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pearson HA, McIntosh S, Ritchey AK, Lobel JS, Rooks Y, Johnston D. Developmental aspects of splenic function in sickle cell diseases. Blood. 1979;53:358–65.

    Article  CAS  PubMed  Google Scholar 

  2. Bonanni P, Grazzini M, Niccolai G, Paolini D, Varone O, Bartoloni A, Bartalesi F, Santini M, Baretti S, Bonito C, Zini P, Mechi M, Niccolini F, Magistri L, Maria P, Boccalini S, Bechini A. Recommended vaccinations for asplenic and hyposplenic adult patients. Hum Vaccin Immunother. 2017;13(2):359–68.

    Article  PubMed  Google Scholar 

  3. Adekile AD, Owunwanne A, Al-Za’abi K, Haider MZ, Tuli M, Al-Mohannadi S. Temporal sequence of splenic dysfunction in sickle cell disease. Am J Hematol. 2002;69:23–7.

    Article  CAS  PubMed  Google Scholar 

  4. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Belleue R, Grover R, Pegelow CH, Vichinsky E. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86(2):776–83.

    Article  CAS  PubMed  Google Scholar 

  5. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for Serogroup B meningococcal vaccine for persons 10 years and older. Pediatrics. 2016;138(3):e20161890.

    Article  Google Scholar 

  6. Kuchar E, Miskiewicz K, Karlikowska M. A review of guidance on immunization in persons with defective or deficient splenic function. Br J Haematol. 2015;171(5):683–94.

    Article  PubMed  Google Scholar 

  7. Winkelstein JA, Drachman RH. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. NEJM. 1968;279(9):459–66.

    Article  CAS  PubMed  Google Scholar 

  8. Johnston RB Jr, Newman SL, Struth AG. An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med. 1973;288(16):803–8.

    Article  PubMed  Google Scholar 

  9. Hand WL, King NL. Serum opsonization of salmonella in sickle cell anemia. Am J Med. 1978;64(3):388–95.

    Article  CAS  PubMed  Google Scholar 

  10. Larcher VF, Wyke RJ, Davis LR, Stroud CE, Williams R. Defective yeast opsonisation and functional deficiency of complement in sickle cell disease. Arch Dis Child. 1982;57(5):343–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bloch EF, Castro O, Gregory JE, Okoh C. Opsonization of pneumococci by whole serum from sickle cell disease patients. J Natl Med Assoc. 1984;76(2):179–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Bjornson AB, Lobel JS, Harr KS. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease. J Infect Dis. 1985;152(4):702–9.

    Article  Google Scholar 

  13. Luo NP, Rowland HA. The serum bactericidal and opsonizing defect in sickle cell anaemia: restoration of activity by control serum. Trans R Soc Trop Med Hyg. 1986;80(2):317–22.

    Article  CAS  PubMed  Google Scholar 

  14. Bjornson AB, Lobel JS. Defective activation and opsonisation; Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. J Clin Invest. 1987;79(2):388–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cetiner S, Akoglu TF, Kiling Y, Akoglu E, Kumi M. Immunological studies in sickle cell disease: comparison of homozygote mild and severe variants. Clin Immunol Immunopathol. 1989;52:32–9.

    Article  Google Scholar 

  16. Koffi KG, Sawadogo D, Meite M, Nanho DC, Tanoh ES, Attia AK, Sanogo I, Sangare A. Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anaemia patients with splenic defects. Hematol J. 2003;4:363–5.

    Article  PubMed  Google Scholar 

  17. Taylor S, Shacks S, Villicana S, Olivares J, Dinkins G. Lymphocyte blastogenic responses in sickle cell disease. Immunol Investig. 1991;20(7):645–55.

    Article  CAS  Google Scholar 

  18. Taylor SC, Shacks SJ, Villicana SM, Olivares J, Dinkins GA. Interferon production in sickle cell disease. Lymphokine Res. 1990;9(3):415–23.

    CAS  PubMed  Google Scholar 

  19. Lederman HM, Connolly MA, Kalpatthi R, Ware RE, Wang WC, Luchtman-Jones L, Waslawiw M, Goldsmith JC, Swift A, Casella JF. Immunologic effects in sickle cell anemia. Pediatrics. 2014;134(4):686–95.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Nagant C, Barbezange C, Dedeken L, Besse-Hammer T, Thomas I, Mahadeb B, Efira A, Ferster A, Corazza F. Alteration of humoral, cellular, and cytokine immune response to inactivated influenza vaccine in patients with sickle cell disease. PLoS One. 2019;14(10):1–16.

    Article  Google Scholar 

  21. Ballester OF, Abdallah JM, Prasad AS. Impaired IgM antibody responses to an influenza virus vaccine in adults with sickle cell anemia. Am J Hematol. 1985;20(4):409–12.

    Article  PubMed  Google Scholar 

  22. Hord J, Windsor B, Koehler M, Blatt J, Janosky J, Mirro J. Diminished antibody response to hepatitis B immunization in children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24(7):548–9.

    Article  PubMed  Google Scholar 

  23. Santoro JD, Myers L, Kanter J. Assessing the immunologic response of a single center’s pneumococcal vaccination protocol in sickle cell disease. J Pediatr Hematol Oncol. 2016;38(3):e102–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Allali S, Chalumeau M, Launay O, Ballas SK, de Montalembert M. Conjugate Haemophilus Influenza type b vaccines for sickle cell disease. Cochrane Database Syst Rev. 2018;8:CD011199. https://doi.org/10.1002/14651858.CD011199.pub3.

    Article  PubMed  Google Scholar 

  25. Center for Disease Control and Prevention. Immunization schedules. Recommended child and adolescent immunization schedule for ages 18 year or younger, United States, 2019. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html. Last Accessed 8/30/2019.

  26. United States Department of Health and Human Services. Evidence-based management of sickle cell disease, expert panel report, 2014: guide to recommendations. https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease. Last accessed 8/29/19.

  27. Center for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). Altered immune competence: anatomic or functional asplenia. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html. Last accessed 18 Nov 2019.

  28. Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices- United States, 2019-20 influenza season. MMWR Recomm Rep. 2019;68(3):1–21. https://www.cdc.gov/mmwr/volumes/68/rr/rr6803a1.htm.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jackson BR, Shahed I, Mahon B. Updated recommendations for the use of typhoid vaccine – Advisory Committee on Immunization Practices, United States, 2015. MMWR. 2015;64(11):305–8. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a4.htm. Last Accessed 9/2/19.

    PubMed  Google Scholar 

  30. Briere EC, Rubin L, Moro P, Cohn A, Clark T, Messonnier N. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices ACIP. February 28, 2014 163:1–14. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6301a1.htm. Last Accessed 8/31/19.

  31. Rubin LG, Voulalas D, Carmody L. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine. Pediatrics. 1989;84(3):509–13.

    CAS  PubMed  Google Scholar 

  32. Goldblatt D, Johnson M, Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. Arch Dis Child. 1996;75(2):159–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kaplan SL, Duckett T, Mahoney DH, Kennedy LL, Dukes CM, Schaffer DM, Mason EO. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus conjugate vaccine in children with sickle hemoglobinopathy or malignancies and after systemic Haemophilus influenzae type b infection. J Pediatr. 1992;120(3):367–70.

    Article  CAS  PubMed  Google Scholar 

  34. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Meissner HC, Baker CJ, Messonier NE. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1–28.

    PubMed  Google Scholar 

  35. Souza AR, Maruyama CM, Safadi MAP, Lopes MH, Azevedo RS, Findlow H, Bai X, Borrow R, Weckx LY. Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease. Vaccine. 2016;34:4327–34.

    Article  CAS  PubMed  Google Scholar 

  36. Marshall GS, Tan L. Understanding the category B recommendation for serogroup B meningococcal vaccine. Pediatrics. 2017;139(5) https://doi.org/10.1542/peds.2016-3484. Originally published online April 4, 2017.

  37. Center for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). June 2019 Meeting recommendations. https://www.cdc.gov/vaccines/acip/recommendations.html. Last accessed 18 Nov 2019.

  38. Kimberlin DW, Brady MT, Jackson MA, Long SS, and Committee on Infectious Diseases. Red book. Report of the Committee on Infectious Diseases. 31st ed: American Academy of Pediatrics; 2018.

    Google Scholar 

  39. De Montalembert M, Abboud MR, Fiquet A, et al. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): results of a phase 3 study. Pediatr Blood Cancer. 2015;62:1427–36.

    Article  PubMed  Google Scholar 

  40. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease in the United States, 1998-2009. Pediatr Infect Dis J. 2013;32:1308–12.

    Article  Google Scholar 

  41. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. NEJM. 2003;348(18):1737–46.

    Article  PubMed  Google Scholar 

  42. Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121(3):562–9.

    Article  PubMed  Google Scholar 

  43. Martin OO, Moquist KL, Hennessy JM, Nelson SC. Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era. Pediatr Blood Cancer. 2018;65:e26713.

    Article  Google Scholar 

  44. Reeves SL, Jary HK, Gondhi J, Kleyn M, Wagner A, Dombkowski KJ. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait and normal hemoglobin. Pediatr Blood Cancer. 2018;65:e27282.

    Article  PubMed  Google Scholar 

  45. Wagner AL, Shrivastwa N, Potter RC, Lyon-Callo SK, Boulton ML. Pneumococcal and meningococcal vaccination among Michigan children with sickle cell disease. J Pediatr. 2018;196:223–9.

    Article  PubMed  Google Scholar 

  46. Oligbu G, Fallaha M, Pay L, Ladhani S. Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol. 2019;185(4):743–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. West Virginia University School of Medicine, Morgantown, WV, USA

    Emily K. Nease & Linda S. Nield

Authors
  1. Emily K. Nease
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda S. Nield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda S. Nield .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Texas Health Science Center, San Antonio, TX, USA

    Deepak M. Kamat

  2. Department of Pediatrics, Division of Hematology-Oncology, The University of Texas Health Science Center, San Antonio, TX, USA

    Melissa Frei-Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nease, E.K., Nield, L.S. (2021). Immunizations in the Child with Sickle Cell Disease. In: Kamat, D., Frei-Jones, M. (eds) Benign Hematologic Disorders in Children. Springer, Cham. https://doi.org/10.1007/978-3-030-49980-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-49980-8_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-49979-2

  • Online ISBN: 978-3-030-49980-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation